Organogenesis (ORGO)
Develops regenerative products for advanced wound care, surgery, and sports medicine.
$1.44
vs last close−0.04 (−3.04%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
−$0.18
Revenue estimate
$52.1M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.04−$0.13−$0.09$0.18$0.31−$0.37−$0.71Pending
Estimate−$0.03$0.04$0.07$0.21$0.22−$0.29−$0.35−$0.18
Surprise+233.3%−425.0%−228.6%−14.3%+44.2%−27.6%−102.9%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$126.7M$86.7M$101.0M$150.9M$225.1M$36.3M$43.8MPending
Estimate$109.6M$90.8M$134.1M$172.7M$172.7M$43.3M$54.3M$52.1M
Surprise+15.6%−4.5%−24.7%−12.6%+30.4%−16.2%−19.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.02 | — | — |
| Sep 2028 | −$0.07 | — | — |
| Jun 2028 | −$0.04 | — | — |
| Mar 2028 | −$0.05 | — | — |
| Dec 2027 | −$0.04 | — | — |
| Sep 2027 | −$0.06 | — | — |
| Jun 2027 | −$0.06 | — | — |
| Mar 2027 | −$0.08 | — | — |
| Dec 2026 | −$0.14 | — | — |
| Nov 2026 | −$0.18 | — | — |
| Aug 2026 | −$0.35 | −$0.71 | −102.9% |
| May 2026 | −$0.29 | −$0.37 | −27.6% |
| Feb 2026 | $0.22 | $0.31 | +44.2% |
| Nov 2025 | $0.21 | $0.18 | −14.3% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Jun 2016 | |||
| Mar 2016 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.02 | — | — | $80.6M | — | — | — |
| Sep 2028 | −$0.07 | — | — | $60.0M | — | — | — |
| Jun 2028 | −$0.04 | — | — | $61.8M | — | — | — |
| Mar 2028 | −$0.05 | — | — | $55.9M | — | — | — |
| Dec 2027 | −$0.04 | — | — | $73.9M | — | — | — |
| Sep 2027 | −$0.06 | — | — | $61.2M | — | — | — |
| Jun 2027 | −$0.06 | — | — | $56.1M | — | — | — |
| Mar 2027 | −$0.08 | — | — | $48.9M | — | — | — |
| Dec 2026 | −$0.14 | — | — | $63.0M | — | — | — |
| Nov 5, 2026 | −$0.18 | — | — | $52.1M | — | — | — |
| Aug 6, 2026 | −$0.35 | −$0.71 | −102.9% | $54.3M | $43.8M | −19.4% | −22.8% |
| May 7, 2026 | −$0.29 | −$0.37 | −27.6% | $43.3M | $36.3M | −16.2% | −6.3% |
| Feb 26, 2026 | $0.22 | $0.31 | +44.2% | $172.7M | $225.1M | +30.4% | −13.2% |
| Nov 6, 2025 | $0.21 | $0.18 | −14.3% | $172.7M | $150.9M | −12.6% | +44.7% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 29, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 10, 2023 | |||||||
| Mar 1, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 16, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 9, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 10, 2019 | |||||||
| Mar 18, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 14, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 11, 2017 | |||||||
| May 12, 2017 | |||||||
| Mar 28, 2017 | |||||||
| Nov 18, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 |